Story · Medicine & Biotech
Medtronic studying safety, effectiveness of its self-expanding TAVR valves in patients with moderate AS
1 outlet · first reported by Cardiovascular Business on
This represents the first randomized trial focused on treating moderate aortic stenosis with Medtronic's self-expanding, supra-annular Evolut platform. (Cardiovascular Business)
Coverage, in order
-
Medtronic studying safety, effectiveness of its self-expanding TAVR valves in patients with moderate ASThis represents the first randomized trial focused on treating moderate aortic stenosis with Medtronic's self-expanding, supra-annular Evolut platform.
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.